In addition, another HMGB1‐specific inhibitor, glycyrrhizin reverses the upregulation of HMGB1 and its receptors (TLR4 and CXCR4) in mice with diabetic neuropathy, improving mechanical and thermal pain threshold in these animals. Here, TLR4 is linked to diabetic neuropathy.